Thiotepa
FDA Approved: * March 9, 1959Pharm Company: * IMMUNEX
Category: Cancer
Thiotepa (INN[3]), sold under the brand name Tepadina, is a medication used to treat cancer.[1][2][4] Thiotepa is an organophosphorus compound with the formula (C2H4N)3PS.[5] It is an analog of N,N′,N′′-triethylenephosphoramide (TEPA), which contains tetrahedral phosphorus and is structurally akin to phosphate. It is manufactured by heating aziridine with thiophosphoryl chloride.[citation... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 0143-9292
Labeler:
Hikma Pharmaceuticals USA Inc.
Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 0143-9309
Labeler:
West-ward Pharmaceuticals Corp
Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 0143-9565
Labeler:
West-ward Pharmaceutical Corp
Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 25021-246
Labeler:
Sagent Pharmaceuticals
Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 43598-171
Labeler:
Dr.reddy's Laboratories Inc.,
Thiotepa 15 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 43598-650
Labeler:
Dr.reddy's Laboratories Inc.,
Thiotepa 15 mg/15mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 54879-014
Labeler:
Sti Pharma LLC
Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 55390-030
Labeler:
Bedford Laboratories
